Rare disease medicines
PTC develops and sells prescription medicines for people with rare genetic and neurological diseases, including treatments it markets itself and products licensed in certain regions.
Customers
Patients, families, and the specialists and hospitals that prescribe rare disease therapies.
Revenue Model
It earns money from selling its approved medicines and from product royalties tied to licensed drug sales.